US Patent 11225653 Methods and compounds for reducing threonyl-tRNA synthetase activity
Patent 11225653 was granted and assigned to University of Vermont on January, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+502 characters)
Article
Patent abstract
The invention includes, in part, methods and compounds for treating diseases and conditions characterized by elevated threonyl-tRNA synthetase (TARS) activity, which include, but are not limited to diseases and conditions in which angiogenesis is elevated as compared to normal. In some embodiments of the invention, a level of a TARS molecule is determined and compared to a control level of TARS to assess a treatment for a disease or condition characterized by elevated TARS activity.
Edits on 15 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Christopher Francklyn0
Jason Botten0
Karen M. Lounsbury0
Edits on 21 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11225653 Methods and compounds for reducing threonyl-tRNA synthetase activity
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11225653
Date of patent
January 18, 2022
Patent application number
16134481
Date Filed
September 18, 2018
Patent primary examiner
Find more entities like US Patent 11225653 Methods and compounds for reducing threonyl-tRNA synthetase activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.